Global Regenerative Medicines Market - Growth, Trends and Forecasts (2017 - 2022)

The global regenerative market is estimated to reach USD 67.6 billion by 2019, from USD 16.4 billion in 2014, growing at a CAGR of 23.2 %. Small molecules and biologics show immense potential in the market and are estimated to grow at a CAGR of 18.9%.Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines which are palliative.

Global Regenerative Medicines Market- Market Dynamics

There are several factors driving and restraining the global regenerative medicines market. Some of these are listed below.


Technological innovations in stem cell therapy and tissue engineering

Growing prevalence of bone and joint diseases

Growing need of orthopedic surgeries

Increasing awareness

Advancements in nanotechnology

Increased in innovation in stem cell therapy


Rules laid down by regulatory bodies

Ethical issues related to regenerative medicines

Cost of the treatment.

The market is segmented on the basis of technology, applications, and geography.

By technology, the market is divided into stem cell therapy, biomaterial, and tissue engineering.

By type of applications, the market is segmented into bone graft substitutes, osteoarticular diseases, central nervous system and cardiovascular.

By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.

North America and Europe account for more than three-fourths of the revenue in 2013. However, technological advancement and research emphasis are growing in the Asia-Pacific region, so this is going to be a potential market for regenerative medicines.

Some of the key players in the market are:

Anika Therapeutics, Inc.

Arthrex, Inc.

Baxter International, Inc.

CONMED Corporation

DePuy Synthes, Inc.

Medtronic, Inc.

What the Report Offers

A wide and in-depth analysis of the market share and market size estimation based on products, applications, and services.

High-level analysis of the competitive landscape, which in turn includes mergers & acquisitions, collaborations, new product launches and new strategies which major players are following to keep pace with the market.

Market analysis for the regenerative medicine market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.




3.1 Global Regenerative medicine market

3.2 Current and Future Trends

3.3 Products in the market

3.4 Market Size and Share estimation

3.5 Regenerative medicine Stakeholders


4.1 Market Drivers

4.1.1 Technological Innovations in Stem Cell Therapy and Tissue Engineering

4.1.2 Growing prevalence of bone and Joint Diseases

4.1.3 Growing need of Orthopaedic Surgeries Fuels the need of Global regenerative Medicine Market

4.1.4 Increasing people Awareness

4.2 Market Restraints

4.2.1 Regulatory Constraints

4.2.2 Ethical Issues

4.2.3 Cost of Treatment

4.3 Regenerative Medicine Goals and Strategies

4.3.1 Current Markets

4.3.2 Geographic Expansion

4.3.3 New Product Innovation

4.4 PorterFive Force Analysis

4.4.1 Bargaining power of suppliers

4.4.2 Bargaining power of buyers

4.4.3 Threat of new entrants

4.4.4 Threat of substitutes

4.4.5 Competitive rivalry


5.1 Introduction

5.2 Market Segmentation, By Type of Technology

5.2.1 Stem Cell Therapy

5.2.2 Biomaterial

5.2.3 Tissue Engineering

5.3 Market Segmentation, By Type of Applications

5.3.1 Bone Graft Substitutes

5.3.2 Osteoarticular Diseases

5.3.3 Dermatology

5.3.4 Cardiovascular

5.3.5 Central nervous system

5.4 Market Segmentation, By Type of Geography

5.4.1 North America US Canada Mexico

5.4.2 Europe UK France Germany Italy Spain

5.4.3 Asia-Pacific India China Japan

5.4.4 Rest of the World

6. Competitive Landscape

6.1 New Product Launch

6.2 Market Share Analysis by Key Players

6.3 Mergers & Acquisitions

6.4 Market Share Analysis

7. Strategies of Potential Companies

7.1 Mesoblast Ltd.

7.2 Athersys Inc.

7.3 Neo Stem Inc.

7.4 StemCells Inc.

7.5 Neuralstem Inc.

8. Strategies of Top 3 Potential Companies

8.1 Cellular Dynamics International, Inc.

8.2 Athersys, Inc

8.3 Cytori Therapeutics, Inc.

9. Company Profiles

9.1 Anika Therapeutics, Inc.

9.2 Arthrex, Inc.

9.3 Baxter International, Inc.

9.4 CONMED Corporation

9.5 DePuy Synthes, Inc.

9.6 Medtronic, Inc.

9.7 Smith & Nephew PLC

9.8 Stryker Corporation

9.9 Zimmer Holdings, Inc.

10. Appendix





Content are not available

Choose License Type